Vimarsana
Biggest News Aggregation in the World

Page 10 - Growth Factor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Growth Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Growth Factor Today - Breaking & Trending Today

Treatment Considerations With TROP2-Targeted Therapy - Vimarsana News

Treatment Considerations With TROP2-Targeted Therapy

Clinical insights on best practices for treating patients with TROP2-targeted therapy.

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment - Vimarsana News

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

A recent study in eClinicalMedicine found that fecal microbiota transplantation, combined with fruquintinib and tislelizumab, significantly improved survival rates in patients with microsatellite stable metastatic colorectal cancer, showing manageable safety and notable increases in progression-free and overall survival.

Patients with advanced HER2-positive breast cancer live longer if treated with pyrotinib, trial shows - Vimarsana News

Patients with advanced HER2-positive breast cancer live longer if treated with pyrotinib, trial shows

Patients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer if they are treated with a new drug called pyrotinib, according to results from the longest follow-up of the PHOEBE randomized clinical trial in China.

New insights into migraine etiology: the role of hepatocyte growth factor - Vimarsana News

New insights into migraine etiology: the role of hepatocyte growth factor

The causal links between pro-inflammatory cytokine expression and migraine.

Atlas of cancer's hidden rules: Unveiling the transcriptomic and epigenetic secrets across 11 tumors - Vimarsana News

Atlas of cancer's hidden rules: Unveiling the transcriptomic and epigenetic secrets across 11 tumors

Researchers have mapped the complex epigenetic and transcriptomic landscape of cancer, revealing key regulatory elements across 11 tumor types that could unlock new insights into cancer progression and metastasis.